Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Mar;64(3):808–816. doi: 10.1086/302294

A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

J Hampe 1, S Schreiber 1, S H Shaw 1, K F Lau 1, S Bridger 1, A J Macpherson 1, L R Cardon 1, H Sakul 1, T J Harris 1, A Buckler 1, J Hall 1, P Stokkers 1, S J van Deventer 1, P Nürnberg 1, M M Mirza 1, J C Lee 1, J E Lennard-Jones 1, C G Mathew 1, M E Curran 1
PMCID: PMC1377799  PMID: 10053016

Abstract

Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, typically starting in early adulthood. IBD is subdivided into two subtypes, on the basis of clinical and histologic features: Crohn disease and ulcerative colitis (UC). Previous genomewide searches identified regions harboring susceptibility loci on chromosomes 1, 3, 4, 7, 12, and 16. To expand our understanding of the genetic risk profile, we performed a 9-cM genomewide search for susceptibility loci in 268 families containing 353 affected sibling pairs. Previous linkages on chromosomes 12 and 16 were replicated, and the chromosome 4 linkage was extended in this sample. New suggestive evidence for autosomal linkages was observed on chromosomes 1, 6, 10, and 22, with LOD scores of 2.08, 2.07, 2.30, and 1.52, respectively. A maximum LOD score of 1.76 was observed on the X chromosome, for UC, which is consistent with the clinical association of IBD with Ullrich-Turner syndrome. The linkage finding on chromosome 6p is of interest, given the possible contribution of human leukocyte antigen and tumor necrosis-factor genes in IBD. This genomewide linkage scan, done with a large family cohort, has confirmed three previous IBD linkages and has provided evidence for five additional regions that may harbor IBD predisposition genes.

Full Text

The Full Text of this article is available as a PDF (294.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arulanantham K., Kramer M. S., Gryboski J. D. The association of inflammatory bowel disease and X chromosomal abnormality. Pediatrics. 1980 Jul;66(1):63–67. [PubMed] [Google Scholar]
  2. Becker K. G., Simon R. M., Bailey-Wilson J. E., Freidlin B., Biddison W. E., McFarland H. F., Trent J. M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9979–9984. doi: 10.1073/pnas.95.17.9979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biemond I., Burnham W. R., D'Amaro J., Langman M. J. HLA-A and -B antigens in inflammatory bowel disease. Gut. 1986 Aug;27(8):934–941. doi: 10.1136/gut.27.8.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bouma G., Oudkerk Pool M., Crusius J. B., Schreuder G. M., Hellemans H. P., Meijer B. U., Kostense P. J., Giphart M. J., Meuwissen S. G., Peña A. S. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin Exp Immunol. 1997 Jul;109(1):175–179. doi: 10.1046/j.1365-2249.1997.4121510.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bouma G., Poen A. C., García-González M. A., Schreuder G. M., Felt-Bersma R. J., Meuwissen S. G., Pena A. S. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics. 1998 May;47(6):451–455. doi: 10.1007/s002510050382. [DOI] [PubMed] [Google Scholar]
  6. Carroll M. C. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 1998;16:545–568. doi: 10.1146/annurev.immunol.16.1.545. [DOI] [PubMed] [Google Scholar]
  7. Cho J. H., Nicolae D. L., Gold L. H., Fields C. T., LaBuda M. C., Rohal P. M., Pickles M. R., Qin L., Fu Y., Mann J. S. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7502–7507. doi: 10.1073/pnas.95.13.7502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Colombel J. F., Grandbastien B., Gower-Rousseau C., Plegat S., Evrard J. P., Dupas J. L., Gendre J. P., Modigliani R., Bélaïche J., Hostein J. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology. 1996 Sep;111(3):604–607. doi: 10.1053/gast.1996.v111.pm8780563. [DOI] [PubMed] [Google Scholar]
  9. Curran M. E., Lau K. F., Hampe J., Schreiber S., Bridger S., Macpherson A. J., Cardon L. R., Sakul H., Harris T. J., Stokkers P. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology. 1998 Nov;115(5):1066–1071. doi: 10.1016/s0016-5085(98)70075-7. [DOI] [PubMed] [Google Scholar]
  10. Delpre G., Kadish U., Gazit E., Joshua H., Zamir R. HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology. 1980 Jun;78(6):1452–1457. [PubMed] [Google Scholar]
  11. Duerr R. H., Barmada M. M., Zhang L., Davis S., Preston R. A., Chensny L. J., Brown J. L., Ehrlich G. D., Weeks D. E., Aston C. E. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet. 1998 Jul;63(1):95–100. doi: 10.1086/301929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fielding J. F. The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J Clin Gastroenterol. 1986 Dec;8(6):655–657. doi: 10.1097/00004836-198612000-00013. [DOI] [PubMed] [Google Scholar]
  13. Forcione D. G., Sands B., Isselbacher K. J., Rustgi A., Podolsky D. K., Pillai S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci U S A. 1996 May 14;93(10):5094–5098. doi: 10.1073/pnas.93.10.5094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fujita K., Naito S., Okabe N., Yao T. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. J Clin Lab Immunol. 1984 Jun;14(2):99–102. [PubMed] [Google Scholar]
  15. Gahmberg C. G., Valmu L., Fagerholm S., Kotovuori P., Ihanus E., Tian L., Pessa-Morikawa T. Leukocyte integrins and inflammation. Cell Mol Life Sci. 1998 Jun;54(6):549–555. doi: 10.1007/s000180050183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gleeson M. H., Walker J. S., Wentzel J., Chapman J. A., Harris R. Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut. 1972 Jun;13(6):438–440. doi: 10.1136/gut.13.6.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hamilton S. R. The differential diagnosis of idiopathic inflammatory disease by colorectal biopsy. Int J Colorectal Dis. 1987 Jun;2(2):113–117. doi: 10.1007/BF01647703. [DOI] [PubMed] [Google Scholar]
  18. Hampe J., Hermann B., Bridger S., MacPherson A. J., Mathew C. G., Schreiber S. The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease. Int J Colorectal Dis. 1998;13(5-6):260–263. doi: 10.1007/s003840050173. [DOI] [PubMed] [Google Scholar]
  19. Hayward P. A., Satsangi J., Jewell D. P. Inflammatory bowel disease and the X chromosome. QJM. 1996 Sep;89(9):713–718. doi: 10.1093/qjmed/89.9.713. [DOI] [PubMed] [Google Scholar]
  20. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet. 1996;30:405–439. doi: 10.1146/annurev.genet.30.1.405. [DOI] [PubMed] [Google Scholar]
  21. Hugot J. P., Laurent-Puig P., Gower-Rousseau C., Caillat-Zucman S., Beaugerie L., Dupas J. L., Van Gossum A., Bonäit-Pellie C., Cortot A., Thomas G. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet. 1994 Aug 15;52(2):207–213. doi: 10.1002/ajmg.1320520216. [DOI] [PubMed] [Google Scholar]
  22. Hugot J. P., Laurent-Puig P., Gower-Rousseau C., Olson J. M., Lee J. C., Beaugerie L., Naom I., Dupas J. L., Van Gossum A., Orholm M. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996 Feb 29;379(6568):821–823. doi: 10.1038/379821a0. [DOI] [PubMed] [Google Scholar]
  23. Idury R. M., Cardon L. R. A simple method for automated allele binning in microsatellite markers. Genome Res. 1997 Nov;7(11):1104–1109. doi: 10.1101/gr.7.11.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Knudtzon J., Ledaal P., Middelthon-Moe M., Aarskog D. 45,X/47,XY,+13 mosaicism and Crohn's disease. Acta Paediatr Scand. 1988 Nov;77(6):922–924. doi: 10.1111/j.1651-2227.1988.tb10784.x. [DOI] [PubMed] [Google Scholar]
  25. Knudtzon J., Svane S. Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand. 1988;223(4):375–378. doi: 10.1111/j.0954-6820.1988.tb15887.x. [DOI] [PubMed] [Google Scholar]
  26. Kohler J. A., Grant D. B. Crohn's disease in Turner's syndrome. Br Med J (Clin Res Ed) 1981 Mar 21;282(6268):950–950. doi: 10.1136/bmj.282.6268.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Koutroubakis I., Manousos O. N., Meuwissen S. G., Pena A. S. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology. 1996 Mar-Apr;43(8):381–393. [PubMed] [Google Scholar]
  28. Kruglyak L., Lander E. S. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 1995 Aug;57(2):439–454. [PMC free article] [PubMed] [Google Scholar]
  29. Kruglyak L., Lander E. S. Limits on fine mapping of complex traits. Am J Hum Genet. 1996 May;58(5):1092–1093. [PMC free article] [PubMed] [Google Scholar]
  30. Küster W., Pascoe L., Purrmann J., Funk S., Majewski F. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet. 1989 Jan;32(1):105–108. doi: 10.1002/ajmg.1320320122. [DOI] [PubMed] [Google Scholar]
  31. Lennard-Jones J. E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2–19. doi: 10.3109/00365528909091339. [DOI] [PubMed] [Google Scholar]
  32. Matise T. C., Perlin M., Chakravarti A. Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet. 1994 Apr;6(4):384–390. doi: 10.1038/ng0494-384. [DOI] [PubMed] [Google Scholar]
  33. Mayberry J. F. Recent epidemiology of ulcerative colitis and Crohn's disease. Int J Colorectal Dis. 1989;4(1):59–66. doi: 10.1007/BF01648555. [DOI] [PubMed] [Google Scholar]
  34. Mirza M. M., Lee J., Teare D., Hugot J. P., Laurent-Puig P., Colombel J. F., Hodgson S. V., Thomas G., Easton D. F., Lennard-Jones J. E. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. J Med Genet. 1998 Mar;35(3):218–221. doi: 10.1136/jmg.35.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nakajima A., Matsuhashi N., Kodama T., Yazaki Y., Takazoe M., Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology. 1995 Nov;109(5):1462–1467. doi: 10.1016/0016-5085(95)90631-2. [DOI] [PubMed] [Google Scholar]
  36. Naom I., Lee J., Ford D., Bowman S. J., Lanchbury J. S., Haris I., Hodgson S. V., Easton D., Lennard-Jones J., Mathew C. G. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet. 1996 Jul;59(1):226–233. [PMC free article] [PubMed] [Google Scholar]
  37. Nordgren S., Fasth S., Hultén L. Anal fistulas in Crohn's disease: incidence and outcome of surgical treatment. Int J Colorectal Dis. 1992 Dec;7(4):214–218. doi: 10.1007/BF00341224. [DOI] [PubMed] [Google Scholar]
  38. Ohmen J. D., Yang H. Y., Yamamoto K. K., Zhao H. Y., Ma Y., Bentley L. G., Huang Z., Gerwehr S., Pressman S., McElree C. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet. 1996 Oct;5(10):1679–1683. doi: 10.1093/hmg/5.10.1679. [DOI] [PubMed] [Google Scholar]
  39. Orholm M., Iselius L., Sørensen T. I., Munkholm P., Langholz E., Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ. 1993 Jan 2;306(6869):20–24. doi: 10.1136/bmj.306.6869.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Orholm M., Munkholm P., Langholz E., Nielsen O. H., Sørensen T. I., Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991 Jan 10;324(2):84–88. doi: 10.1056/NEJM199101103240203. [DOI] [PubMed] [Google Scholar]
  41. Peeters M., Nevens H., Baert F., Hiele M., de Meyer A. M., Vlietinck R., Rutgeerts P. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996 Sep;111(3):597–603. doi: 10.1053/gast.1996.v111.pm8780562. [DOI] [PubMed] [Google Scholar]
  42. Perri F., Annese V., Piepoli A., Napolitano G., Lombardi G., Ciavarella G., Di Giorgio G., Andriulli A. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol. 1998 Feb;30(1):56–61. [PubMed] [Google Scholar]
  43. Plevy S. E., Targan S. R., Yang H., Fernandez D., Rotter J. I., Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology. 1996 Apr;110(4):1053–1060. doi: 10.1053/gast.1996.v110.pm8612993. [DOI] [PubMed] [Google Scholar]
  44. Podolsky D. K. Inflammatory bowel disease (1) N Engl J Med. 1991 Sep 26;325(13):928–937. doi: 10.1056/NEJM199109263251306. [DOI] [PubMed] [Google Scholar]
  45. Price W. H. A high incidence of chronic inflammatory bowel disease in patients with Turner's syndrome. J Med Genet. 1979 Aug;16(4):263–266. doi: 10.1136/jmg.16.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Probert C. S., Jayanthi V., Rampton D. S., Mayberry J. F. Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. Int J Colorectal Dis. 1996;11(1):25–28. doi: 10.1007/BF00418851. [DOI] [PubMed] [Google Scholar]
  47. Purrmann J., Korsten S., Bertrams J., Miller B., Lapsien B., Münch H., Reis H. E., Strohmeyer G. HLA-Haplotypstudie bei familiärem Morbus Crohn. Z Gastroenterol. 1985 Aug;23(8):432–437. [PubMed] [Google Scholar]
  48. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 1990 Feb;46(2):229–241. [PMC free article] [PubMed] [Google Scholar]
  49. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998 Apr;22(4):382–389. doi: 10.1007/s002689900401. [DOI] [PubMed] [Google Scholar]
  50. Roth M. P., Petersen G. M., McElree C., Vadheim C. M., Panish J. F., Rotter J. I. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology. 1989 Apr;96(4):1016–1020. doi: 10.1016/0016-5085(89)91618-1. [DOI] [PubMed] [Google Scholar]
  51. Roussomoustakaki M., Satsangi J., Welsh K., Louis E., Fanning G., Targan S., Landers C., Jewell D. P. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997 Jun;112(6):1845–1853. doi: 10.1053/gast.1997.v112.pm9178675. [DOI] [PubMed] [Google Scholar]
  52. Russell A. S., Percy J. S., Schlaut J., Sartor V. E., Goodhart J. M., Sherbaniuk R. W., Kidd E. G. Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis. 1975 Apr;20(4):359–361. doi: 10.1007/BF01237793. [DOI] [PubMed] [Google Scholar]
  53. Satsangi J., Grootscholten C., Holt H., Jewell D. P. Clinical patterns of familial inflammatory bowel disease. Gut. 1996 May;38(5):738–741. doi: 10.1136/gut.38.5.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Satsangi J., Parkes M., Louis E., Hashimoto L., Kato N., Welsh K., Terwilliger J. D., Lathrop G. M., Bell J. I., Jewell D. P. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996 Oct;14(2):199–202. doi: 10.1038/ng1096-199. [DOI] [PubMed] [Google Scholar]
  55. Satsangi J., Welsh K. I., Bunce M., Julier C., Farrant J. M., Bell J. I., Jewell D. P. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 1996 May 4;347(9010):1212–1217. doi: 10.1016/s0140-6736(96)90734-5. [DOI] [PubMed] [Google Scholar]
  56. Scarpa R., Lubrano E., Castiglione F., Morace F., Ames P. R., Oriente P. Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association. Clin Exp Rheumatol. 1996 Jul-Aug;14(4):449–450. [PubMed] [Google Scholar]
  57. Schmid P., Itin P., Cherry G., Bi C., Cox D. A. Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol. 1998 Feb;152(2):485–493. [PMC free article] [PubMed] [Google Scholar]
  58. Schreiber S., Heinig T., Panzer U., Reinking R., Bouchard A., Stahl P. D., Raedler A. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology. 1995 Jan;108(1):21–33. doi: 10.1016/0016-5085(95)90004-7. [DOI] [PubMed] [Google Scholar]
  59. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996 Nov;39(5):690–697. doi: 10.1136/gut.39.5.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Smolen J. S., Gangl A., Polterauer P., Menzel E. J., Mayr W. R. HLA antigens in inflammatory bowel disease. Gastroenterology. 1982 Jan;82(1):34–38. [PubMed] [Google Scholar]
  61. Thompson N. P., Driscoll R., Pounder R. E., Wakefield A. J. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ. 1996 Jan 13;312(7023):95–96. doi: 10.1136/bmj.312.7023.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Toyoda H., Wang S. J., Yang H. Y., Redford A., Magalong D., Tyan D., McElree C. K., Pressman S. R., Shanahan F., Targan S. R. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993 Mar;104(3):741–748. doi: 10.1016/0016-5085(93)91009-7. [DOI] [PubMed] [Google Scholar]
  63. Tysk C., Lindberg E., Järnerot G., Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988 Jul;29(7):990–996. doi: 10.1136/gut.29.7.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Uyar F. A., Imeryüz N., Saruhan-Direskeneli G., Ceken H., Ozdoğan O., Sahin S., Tözün N. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur J Immunogenet. 1998 Aug;25(4):293–296. doi: 10.1046/j.1365-2370.1998.00104.x. [DOI] [PubMed] [Google Scholar]
  65. van den Berg-Loonen E. M., Dekker-Saeys B. J., Meuwissen S. G., Nijenhuis L. E., Engelfriet C. P. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet. 1977 Jun;4(3):167–175. doi: 10.1111/j.1744-313x.1977.tb00899.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES